Article
Beyond mecA: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA.
Antimicrobial agents and chemotherapy - 4 Feb 2026
Sassman Melissa, Karolak Michele, Dallaire Margeurite, Schaffer Claire E, Gartner Carlos, Vary Calvin, Rosato Roberto R, Rosato Adriana E
Abstract excerpt
High-level resistance to ceftaroline, a fifth-generation β-lactam critical for treating methicillin-resistant Staphylococcus aureus (MRSA), is an emerging threat to global health. While resistance is traditionally attributed to mecA-mediated expression of PBP2a, our study reveals a previously unrecognized mechanism. We show that high-level resistance to ceftaroline can arise independently of ceftaroline exposure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
